Patents by Inventor Susan M. Kramer

Susan M. Kramer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
    Patent number: 7364734
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: April 29, 2008
    Assignee: Genentech, Inc.
    Inventors: Marvin R. Garovoy, Susan M. Kramer, Russell L. Dedrick, Karen Starko
  • Treatment of LFA-1 associated disorders with increasing doses
    Publication number: 20040047859
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Application
    Filed: September 5, 2003
    Publication date: March 11, 2004
    Applicants: Genentech, Inc., Xoma Ltd.
    Inventors: Marvin R. Garovoy, Susan M. Kramer, Russell L. Dedrick, Karen Starko
  • Treatment method
    Publication number: 20030223988
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Application
    Filed: June 20, 2003
    Publication date: December 4, 2003
    Applicants: Genentech, Inc., Xoma Technology, Ltd.
    Inventors: Russell L. Dedrick, Marvin R. Garovoy, Susan M. Kramer, Karen M. Starko
  • Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
    Patent number: 6652855
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need therof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: November 25, 2003
    Assignees: Genentech, Inc., XOMA Ltd.
    Inventors: Marvin R. Garovoy, Susan M. Kramer, Russell L. Dedrick, Karen Starko
  • Treatment method
    Patent number: 6582698
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: June 24, 2003
    Assignees: Genentech, Inc., XOMA Technology, Ltd.
    Inventors: Russell L. Dedrick, Marvin R. Garovoy, Susan M. Kramer, Karen M. Starko